Andrew J Levine1, Manuel Palomo1, Charles H Hinkin2, Miguel Valdes-Sueiras3, Enrique Lopez4, Glenn Mathisen3, Suzanne Donovan3, Elyse J Singer1. 1. National Neurological AIDS Bank, Department of Neurology, David Geffen School of Medicine at UCLA. 2. Veterans Affairs Greater Los Angeles Healthcare System ; Department of Psychiatry and Behavioral Sciences, David Geffen School of Medicine at UCLA. 3. National Neurological AIDS Bank, Department of Neurology, David Geffen School of Medicine at UCLA ; Olive View-UCLA Medical Center, Sylmar, CA, USA. 4. Department of Psychiatry and Behavioral Sciences, David Geffen School of Medicine at UCLA ; Department of Psychiatry and Behavioral Neuroscience, Cedars-Sinai Medical Center, Los Angeles.
Abstract
BACKGROUND: A substantial number of Spanish-speaking individuals from Mexico and Central America are now living in the United States. These individuals are at heightened risk for HIV infection and, due to late diagnosis and limited resources, for HIV-associated neurocognitive disorders (HAND). Early detection is key, yet adequate methods for detecting HAND in Spanish speakers, especially in resource-poor areas, remains problematic. Therefore, it is necessary to identify accurate yet efficient neurocognitive screening tools that are appropriate for use in resource-limited AIDS clinics serving Spanish-speaking patients. METHODS: Twenty-one Spanish-speaking, HIV-positive adults who migrated from Mexico or Central America underwent neuromedical and neurocognitive evaluation in Spanish. The concordance of three neurocognitive screening measures (the HIV Dementia Scale [HDS], the Mini-Mental State Examination [MMSE], and the NEUROPSI) with a comprehensive neuropsychological battery was examined. In addition, accuracy in detecting neurocognitive impairment using standard and alternative cutoff scores was examined. RESULTS: The HDS and the NEUROPSI showed high correlation with the comprehensive neuropsychological battery. The HDS and the NEUROPSI also had the highest sensitivity (67% and 75%, respectively) and specificity (50% and 38%, respectively). Both measures also showed greater sensitivity than the MMSE to very mild forms of HAND. CONCLUSION: In this small sample of HIV-positive Spanish speakers from Mexico and Central America living in the United States, the HDS and the NEUROPSI demonstrated reasonable accuracy in detecting neurocognitive impairment, while the MMSE demonstrated very poor accuracy. The HDS and the NEUROPSI were equally sensitive in detecting mild HAND. Continued test development is required to capture this disorder, especially in resource-limited settings.
BACKGROUND: A substantial number of Spanish-speaking individuals from Mexico and Central America are now living in the United States. These individuals are at heightened risk for HIV infection and, due to late diagnosis and limited resources, for HIV-associated neurocognitive disorders (HAND). Early detection is key, yet adequate methods for detecting HAND in Spanish speakers, especially in resource-poor areas, remains problematic. Therefore, it is necessary to identify accurate yet efficient neurocognitive screening tools that are appropriate for use in resource-limited AIDS clinics serving Spanish-speaking patients. METHODS: Twenty-one Spanish-speaking, HIV-positive adults who migrated from Mexico or Central America underwent neuromedical and neurocognitive evaluation in Spanish. The concordance of three neurocognitive screening measures (the HIV Dementia Scale [HDS], the Mini-Mental State Examination [MMSE], and the NEUROPSI) with a comprehensive neuropsychological battery was examined. In addition, accuracy in detecting neurocognitive impairment using standard and alternative cutoff scores was examined. RESULTS: The HDS and the NEUROPSI showed high correlation with the comprehensive neuropsychological battery. The HDS and the NEUROPSI also had the highest sensitivity (67% and 75%, respectively) and specificity (50% and 38%, respectively). Both measures also showed greater sensitivity than the MMSE to very mild forms of HAND. CONCLUSION: In this small sample of HIV-positive Spanish speakers from Mexico and Central America living in the United States, the HDS and the NEUROPSI demonstrated reasonable accuracy in detecting neurocognitive impairment, while the MMSE demonstrated very poor accuracy. The HDS and the NEUROPSI were equally sensitive in detecting mild HAND. Continued test development is required to capture this disorder, especially in resource-limited settings.
Entities:
Keywords:
HIV Dementia Scale; HIV-associated neurocognitive disorders; Mini-Mental State Examination; NEUROPSI; Spanish speaking
Authors: Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor Journal: J Neurovirol Date: 2003-04 Impact factor: 2.643
Authors: Melissa A Sanchez; George F Lemp; Carlos Magis-Rodríguez; Enrique Bravo-García; Susan Carter; Juan D Ruiz Journal: J Acquir Immune Defic Syndr Date: 2004-11-01 Impact factor: 3.731
Authors: Kara Anne Bottiggi; Jason J Chang; Frederick A Schmitt; Malcolm J Avison; Yunanan Mootoor; Avindra Nath; Joseph R Berger Journal: J Neurol Sci Date: 2007-05-04 Impact factor: 3.181
Authors: Erin E Morgan; Steven Paul Woods; J Cobb Scott; Meredith Childers; Jennifer Marquie Beck; Ronald J Ellis; Igor Grant; Robert K Heaton Journal: J Clin Exp Neuropsychol Date: 2007-04-20 Impact factor: 2.475
Authors: Enrique López; Alexander J Steiner; Kimberly Smith; Nicholas S Thaler; David J Hardy; Andrew J Levine; Hussah T Al-Kharafi; Cristina Yamakawa; Karl Goodkin Journal: Appl Neuropsychol Adult Date: 2016-08-15 Impact factor: 2.248
Authors: Susanna L Lamers; Rebecca Rose; Ekaterina Maidji; Melissa Agsalda-Garcia; David J Nolan; Gary B Fogel; Marco Salemi; Debra L Garcia; Paige Bracci; William Yong; Deborah Commins; Jonathan Said; Negar Khanlou; Charles H Hinkin; Miguel Valdes Sueiras; Glenn Mathisen; Suzanne Donovan; Bruce Shiramizu; Cheryl A Stoddart; Michael S McGrath; Elyse J Singer Journal: J Virol Date: 2016-09-29 Impact factor: 5.103